Malaysia · 
What does Malaysian Life Sciences Capital Fund invest in?
Malaysian Life Sciences Capital Fund invests most often at Series C and Series D (67% of the rounds on record), in sectors such as Life Sciences.
Malaysian Life Sciences Capital Fund highlights
- 01
12 rounds on record
- 02
Mostly Series C and Series D: 67% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- VC firm
- Cheque size
- Not stated
- Sectors
- Life Sciences
- Based in
- Kuala Lumpur, Malaysia
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first12 appearances
- 2014
1 round
- Mar
- 2013
3 rounds
- Nov
- Jul
- Feb
- 2012
1 round
- Jan
- 2011
2 rounds
- Oct
- May
- 2009
2 rounds
- Aug
- Apr
- 2008
2 rounds
- Oct
- May
- 2007
1 round
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
GKGanesh KishoreManaging Member of Spruce Capital Partners LLCiForm ADV
GYGregory YoungManaging Member of Spruce Capital Partners LLCiForm ADV
RWRoger WyseManaging Member of Spruce Capital Partners LLCiForm ADV
We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$117Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Spruce Capital Partners LLC
- SEC number
- CRD 170820
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Small Bone InnovationsBought by Stryker Corporation$375MJun 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.